查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197538

醫學模擬市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Medical Simulation Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022 年至 2027 年的預測期內，醫療模擬市場預計將以 12.4% 的複合年增長率增長。

醫學模擬在各醫療機構應對 COVID-19 大流行中發揮了重要作用。 大流行期間，各種醫療保健機構都部署了模擬培訓，以完善規程、促進實踐中的變化、確定安全漏洞並培訓重新部署到不熟悉的角色的衛生工作者。 根據 2021 年 2 月號 Stimulation Healthcare 發表的題為“在 COVID-19 大流行期間實施模擬訓練”的研究，模擬在應對大流行的過程中至關重要。 從備災和危機資源管理中的應用，到解決基於系統的問題，如識別安全差距、制定感染控制策略和改進臨床管理協議，模擬被認為是有效的。 因此，在大流行期間，醫療保健以越來越多的方式採用醫學模擬，證明了大流行對市場增長的積極影響。

推動醫療模擬市場增長的因素包括持續的技術進步、對患者安全的日益關注以及對微創治療的需求不斷增長。

隨著世界各地醫療機構的技術進步和創新，微創手術 (MIS) 多年來一直被認為是最理想的外科手術，因此持續發展。 MIS 作為傳統開放手術的替代方案，在普通外科手術中具有重要作用，包括腹腔鏡技術、心臟手術、婦科和骨科。

根據 2022 年 2 月在臨床脊柱外科雜誌上發表的題為“微創與開放式脊柱手術患者偏好、理解和情緒的比較”的研究論文，在開放式手術和微創手術 (MIS) 之間進行選擇時，最重要的是研究中患者確定的標準是長期結果、外科醫生的建議和並發症的風險。 患者還認為 MIS 手術在術後疼痛、並發症風險、恢復時間、成本和麻醉需要方面優於開放手術。 大多數患者似乎更喜歡微創治療。 患者普遍認為 MIS 手術比開放手術更受歡迎。 因此，對 MIS 不斷增長的需求有望推動醫療模擬市場。

此外，根據 2022 年 7 月發表在印度臨床麻醉雜誌上的一項名為“考慮模擬培訓以確保沙特阿拉伯利雅得專家麻醉師的患者安全”的研究，高級麻醉醫師是仍然積極參與患者護理和工作，並認為模擬可用於識別和解決作為醫療保健專業人員工作時與年齡相關的挑戰。 它有助於確定不稱職、發展技能並協助麻醉師規劃他們未來的臨床職業。 因此，隨著對患者安全問題的日益關注，醫生可能會將醫療模擬培訓作為其職業生涯的重要組成部分，從而增加對醫療刺激產品和服務的需求。 隨著標準化患者模擬器的使用，醫療模擬設備的使用在過去幾年中經歷了快速增長，這主要是由於技術進步和醫療保健領域的日益普及。 Metiman Simulator 已被證明是 CAE Simulator 最近開發的最先進和最逼真的模擬器之一。 因此，醫療模擬領域各種技術進步的興起增加了其在醫療保健領域用於培訓醫務人員的應用，這將推動預測期內研究的市場增長。

醫療模擬市場趨勢

預計在預測期內心臟手術模擬器將佔據較大的市場份額

由於心血管疾病 (CVD) 在世界範圍內的高發率，醫院、研究中心對心臟模擬器的採用持續增加，這是由於手術和其他治療程序的增加。. 例如，根據疾病控制和預防中心 2022 年 7 月的更新，到 2020 年，約有 2000 萬 20 歲以上的美國人將患有冠狀動脈疾病 (CAD)，這將導致約 382,□□820 人死亡。由於 2020 年和因此，由於心血管疾病的高患病率和高死亡率，全球對有效和先進治療的需求正在增加，這推動了對心臟手術模擬器的需求，並且預計該領域在預測期內將有顯著增長。 此外，根據 2020 年 2 月發表的文章“法國的心力衰竭 (HF)：慢性心力衰竭的管理和現實生活中心力衰竭的風險”，法國約有 100 萬人受到心力衰竭的影響（ HF) 儘管有完善的治療管理，HF 仍與大約 70,000 例死亡和超過 150,000 例住院有關。 此外，心臟模擬已成為大多數專業外科教育和培訓的可行輔助手段，因此，隨著 CVD 的高負擔，研究部門預計將在預測期內增長。

此外，市場上的主要參與者推出了幾款創新產品，進一步提高了這些心臟模擬器的採用率，使它們對用戶和預算更友好，這一因素也有助於心臟手術模擬器的增長。預計支持 例如，2022 年 3 月，為醫院和醫護人員提供數字學習解決方案的領先提供商 MedLern 宣布了一個創新的在線復甦培訓平台，該平台不需要導師監督，由協會和挪度醫療技術公司共同開發和交付。 因此，CVD 的高患病率和不斷增加的患病率，加上對微創治療的認識不斷提高，預計將推動全球越來越多的醫院採用心臟手術模擬器。 因此，由於上述原因，預計心臟手術模擬器部分在預測期內將有顯著增長。

預計在預測期內北美將主導醫療模擬市場

在預測期內，預計北美將主導醫療模擬器市場。 需要手術的慢性病患病率上升、技術進步以及主要參與者的存在等因素預計將對該地區醫療模擬器設備的增長做出重大貢獻。 例如，根據加拿大公共衛生署 2021 年 12 月的一份報告，每 100,000 名 65 歲及以上人群的缺血性心髒病粗發病率為男性 2,306.9 例，女性為 1,537 例，男性慢性阻塞性肺病發病率為 1,750.6 例。 , 1,411.4 為女性。 此外，根據 Globocan 2020 報告，北美地區的癌症發病人數估計將從 2020 年的 260 萬增加到 2040 年的 350 萬，因此該地區的慢性病負擔很重。因此，預計在預測期內，該地區採用醫療模擬器的人數將會增加。

此外，該地區越來越多地採用微創手術，預計這將推動醫療模擬市場的增長，因為模擬有助於實際外科手術。 例如，根據 2021 年 11 月發表的一項題為“美國微創附件手術使用趨勢”的研究，與開放手術相比，更多因良性原因接受卵巢切除術或卵巢囊腫切除術的女性更有可能接受微創手術手術由於較少的問題導致微創手術。 此外，該地區的主要參與者推出了多項創新產品，促進了這些令人興奮的服務和商品的採用。 例如，2020 年 10 月，GIGXR, Inc. 推出了面向醫療和護理學校的 HoloPatient Remote 和 GIG Mobile。 因此，由於上述因素，北美地區有望在預測期內佔據醫療模擬市場的很大份額。

醫學模擬市場競爭者分析

市場高度分散，參與者眾多。 中小玩家眾多，競爭激烈。 在過去幾年中，模擬技術的日益普及不斷吸引新的參與者進入市場。 現有的參與者正試圖通過價格、質量和技術使自己脫穎而出。 市場參與者包括 3D Systems、加拿大航空電子公司 (CAE)、Gaumard Scientific Company Inc、Kyoto Kagaku、Laerdal Medical、Limbs & Things Ltd。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 技術進步
    • 對患者安全的擔憂加劇
    • 對微創治療的需求不斷增長
  • 市場製約因素
    • 模擬器成本高
    • 籌資能力有限，尤其是在發展中國家和不發達國家
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品/服務
    • 按產品分類
      • 介入/手術模擬器
      • 腹腔鏡手術模擬器
      • 婦科手術模擬器
      • 心臟手術模擬器
      • 關節鏡手術模擬器
      • 其他產品
      • 任務培訓師
      • 其他產品和服務
    • 服務/軟件
      • 基於網絡的模擬
      • 醫學模擬軟件
      • 模擬訓練服務
      • 其他服務和軟件
  • 按技術
    • 高保真模擬器
    • 中等再現性模擬器
    • 低保真模擬器
  • 最終用戶
    • 學術和研究機構
    • 醫院
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • 3D Systems
    • Canadian Aviation Electronics（CAE）
    • 3B Scientific GmbH Inc.（Cardionics Inc.）
    • Gaumard Scientific Company Inc.
    • Kyoto Kagaku Co. Ltd
    • Laerdal Medical
    • Limbs & Things Ltd
    • Medaphor
    • Mentice AB
    • Nasco
    • Operative Experience, Inc.
    • Simulab Corporation
    • Simulaids Inc.
    • VirtaMed AG

第7章 市場機會與今後動向

簡介目錄
Product Code: 55897

The medical simulation market is projected to register a CAGR of 12.4% during the forecast period, 2022-2027.

Medical Simulation has played a critical role in response to the COVID-19 pandemic in various medical institutions. Simulation training is deployed at various healthcare institutions throughout the pandemic to refine protocols, facilitate practice changes, uncover safety gaps, and train redeployed healthcare workers in unfamiliar roles. According to the study titled "Implementation of Simulation Training During the COVID-19 Pandemic" published in the Stimulation Healthcare February 2021, in the process of responding to the pandemic, simulation was crucial. It was thought that simulation would be a good way to deal with system-based problems like identifying safety gaps, developing infection control strategies, and improving clinical management protocols due to its applications in disaster preparedness and crisis resource management. Thus, healthcare has increasingly adopted medical simulation during the pandemic in many ways showing that the pandemic has a positive impact on market growth.

The propelling factors for the growth of the medical simulation market include continuous technological advancements, increasing concerns over patient safety, and growing demand for minimally invasive treatments.

Technological advancement and innovation in health care facilities across the world have seen Minimally invasive surgery (MIS) grow as it is viewed as the most desirable surgical procedure for years now. MIS plays an essential role in general surgery as an alternative to traditional open surgery including laparoscopic techniques, cardiac surgeries, gynecology, orthopedic, etc.

According to the research article titled "Comparison of Patient Preference, Understanding, and Sentiment for Minimally Invasive Versus Open Spine Surgery "published in Clinical Spine Surgery, February 2022, long-term outcomes, surgeon's recommendation, and complication risk were the most important criteria identified by patients when choosing between open and minimally invasive surgery (MIS). Patients also perceived MIS surgery to have advantages over open surgery in postoperative pain, complication risk, recovery time, cost, and anesthesia requirement. Most patients seem to prefer a minimally invasive approach to their treatment. Patients view MIS surgery more favorably than open surgery overall. Thus, a rise in the demand for MIS is anticipated to drive the medical simulation market.

Moreover, according to the study titled "Considering simulation training to ensure patient safety for expert anesthesiologists over the age of 60 in Saudi Arabia" published in the Indian Journal of Clinical Anaesthesia in July 2022, In Riyadh, Saudi Arabia, senior anesthesiologists are still actively involved in patient care and their duties, and they feel that simulation can help them recognize and address age-related problems in their work as medical professionals. Determining incompetence, enhancing skills, and assisting anesthesiologists in making plans for their future clinical careers. Therefore, as patient safety concerns increase, physicians may use medical simulation training as a crucial component of their careers, which will increase the demand for medical stimulation products and services. The use of medical simulation devices, along with standardized patient simulators, has gained rapid growth over the last few years, mainly due to increasing technological advancements and their adoption in the field of healthcare. The METIman simulator is found to be one of the most advanced and realistic simulators in recent times, developed by the CAE simulators. Thus, the rise in various technological advancements in the field of medical simulation is increasing the applications in healthcare to train healthcare professionals, and because of this, the growth of the market studied is expected to propel over the forecast period.

Medical Simulation Market Trends

Cardiac Surgical Simulators is Expected to Hold a Significant Market Share Over Forecast Period

Owing to the high prevalence of cardiovascular diseases (CVDs) around the world, the adoption rate of the cardiac simulator in hospitals, and research centers is continuously increasing due to the rising number of surgical and other treatment procedures. For instance, according to the July 2022 update of the Centers for Disease Control and Prevention, in 2020, about 20.1 million Americans of age 20 years and older had coronary artery disease (CAD) and it was responsible for about 382,820 deaths 2020 and hence, owing to the high prevalence and mortality due to the cardiovascular diseases, the demand for effective and advanced treatment is increasing globally, which is expected to drive the demand of the cardiac surgical simulators and segment is expected to have significant growth over the forecast period. Further, as per the article titled "Heart failure (HF) in France: chronic heart failure therapeutic management and risk of cardiac decompensation in real-life setting", published in February 2020, in France, around one million persons would be affected by heart failure (HF); there are nearly 70,000 deaths related to HF, and more than 150,000 hospitalizations despite well-defined treatment management. Moreover, cardiac simulation has emerged as a feasible adjunct to surgical education and training for most specialties, and thus, with the high burden of CVDs, the studied segment is expected to grow over the forecast period.

In addition, there have been several innovative product launches by the key players in the market which is further increasing the adoption of these cardiac simulators making them more user and budget-friendly, this factor is also expected to boost the growth of cardiac surgical simulators. For instance, in March 2022, MedLern, a leading digital learning solution for hospitals and healthcare professionals, unveiled an innovative, online resuscitation training platform that does not require instructor oversight, and this online program, HeartCodeComplete is co-developed and powered by the American Heart Association and Laerdal Medical technology. Therefore, the high and increasing prevalence of CVDs coupled with the growing awareness regarding minimally invasive treatments and the rising number of hospitals worldwide is expected to propel the adoption of the cardiac surgical simulator. Thus, due to the above-mentioned reasons, the cardiac surgical simulator segment is expected to have significant growth over the forecast period.

North America is Expected to Dominate the Medical Simulation Market Over the Forecast Period

North America is expected to dominate the market for medical simulators over the forecast period. The factors such as the growing prevalence of chronic diseases that require surgeries, technological advancements, and the presence of major players in this region is expected to be the major contributor to the growth of medical simulator devices. For instance, according to a report published by the Public Health Agency of Canada in December 2021, the crude incidence rate per 100,000 persons aged 65 years and more for ischemic heart disease was 2,306.9 in men and 1,537 for women and chronic obstructive pulmonary disease was 1,750.6 in men and 1,411.4 in women. In addition, according to the Globocan 2020 report, the estimated cancer prevalence in Northern America region is expected to increase from 2.6 million cases in 2020 to 3.5 million cases by 2040 and hence, owing to the high burden of chronic diseases in the region, the adoption of medical simulators is expected to increase in the region over the forecast period.

Further, the growing adoption of minimally invasive surgeries in the region is expected to boost growth in the medical simulation market as simulation helps in getting hands-on for real surgical procedures. For instance, according to the research study published in November 2021, titled "Trends in the Use of Minimally Invasive Adnexal Surgery in the United States", most women who undergo oophorectomy and ovarian cystectomy for benign causes receive minimally invasive surgery as fewer problems are linked to minimally invasive surgery than laparotomy. In addition, the major players in this region have launched several innovative products, which is boosting the adoption of these stimulating services and goods. For Instance, in October 2020, -GIGXR, Inc., a provider of the medical simulator immersive learning System for instructor-led teaching and training, launched the HoloPatient Remote and GIG Mobile for medical and nursing schools. Therefore, due to the aforementioned factors, the north American region is expected to hold a significant share in the medical simulation market over the forecast period.

Medical Simulation Market Competitor Analysis

The market is highly fragmented with many players. With many small and medium players, the competition is high. The market has been experiencing the entry of new players over the last few years, owing to the rising popularity of simulation technology. The existing players are differentiating on the basis of price, quality, and technology. some of the market players are 3D Systems, Canadian Aviation Electronics (CAE), Gaumard Scientific Company Inc., Kyoto Kagaku Co. Ltd, Laerdal Medical, Limbs & Things Ltd etc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements
    • 4.2.2 Increasing Concerns over Patient Safety
    • 4.2.3 Increasing Demand for Minimally Invasive Treatments
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Simulators
    • 4.3.2 Limited Availability of Funds, Especially in the Developing and Underdeveloped Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Products and Services
    • 5.1.1 Products
      • 5.1.1.1 Interventional/Surgical Simulators
      • 5.1.1.1.1 Laparoscopic Surgical Simulators
      • 5.1.1.1.2 Gynecology Surgical Simulators
      • 5.1.1.1.3 Cardiac Surgical Simulators
      • 5.1.1.1.4 Arthroscopic Surgical Simulators
      • 5.1.1.1.5 Other Products
      • 5.1.1.2 Task Trainers
      • 5.1.1.3 Other Products and Services
    • 5.1.2 Services and Software
      • 5.1.2.1 Web-based Simulation
      • 5.1.2.2 Medical Simulation Software
      • 5.1.2.3 Simulation Training Services
      • 5.1.2.4 Other Services and Software
  • 5.2 By Technology
    • 5.2.1 High-fidelity Simulators
    • 5.2.2 Medium-fidelity Simulators
    • 5.2.3 Low-fidelity Simulators
  • 5.3 By End User
    • 5.3.1 Academic and Research Institutes
    • 5.3.2 Hospitals
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3D Systems
    • 6.1.2 Canadian Aviation Electronics (CAE)
    • 6.1.3 3B Scientific GmbH Inc. (Cardionics Inc.)
    • 6.1.4 Gaumard Scientific Company Inc.
    • 6.1.5 Kyoto Kagaku Co. Ltd
    • 6.1.6 Laerdal Medical
    • 6.1.7 Limbs & Things Ltd
    • 6.1.8 Medaphor
    • 6.1.9 Mentice AB
    • 6.1.10 Nasco
    • 6.1.11 Operative Experience, Inc.
    • 6.1.12 Simulab Corporation
    • 6.1.13 Simulaids Inc.
    • 6.1.14 VirtaMed AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS